Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1221 studies found for:    Graft-versus-host disease
Show Display Options
Rank Status Study
1 Completed Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT
Condition: Graft-Versus-Host Disease
Intervention: Drug: Cyclosporine
2 Recruiting A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Graft vs Host Disease
Intervention: Biological: Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease
3 Recruiting Carfilzomib for the Prevention of Graft Versus Host Disease
Condition: Graft-versus-host Disease
Intervention: Drug: carfilzumib
4 Completed Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease
Conditions: Graft Versus Host Disease;   Ophthalmologic Complications
Interventions: Biological: graft versus host disease prophylaxis/therapy;   Other: questionnaire administration;   Procedure: optical coherence tomography
5 Completed Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
Conditions: Graft Versus Host Disease;   Stem Cell Transplantation
Intervention: Drug: voriconazole
6 Recruiting Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
Conditions: Acute Graft-versus-Host Disease;   Allogeneic Stem Cell Transplant
Intervention: Procedure: Blood samples
7 Recruiting Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease
Condition: Graft -Versus-host-disease
Intervention: Biological: Mesenchymal stromal cells
8 Recruiting Mesenchymal Stromal Cells for Acute Graft Versus Host Disease
Condition: Acute GVH Disease
Intervention: Biological: Mesenchymal stromal cell therapy
9 Not yet recruiting Clinical Trial With MSC for Graft Versus Host Disease Treatment
Condition: Acute Graft Versus Host Disease
Intervention: Drug: Adult Allogeneic Mesenchymal cells from adipose tissue.
10 Completed Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Interventions: Drug: cyclosporine;   Drug: hydroxychloroquine;   Drug: prednisone;   Drug: tacrolimus
11 Completed Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract
Condition: Graft Versus Host Disease
Intervention: Drug: beclomethasone dipropionate
12 Enrolling by invitation Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease
Condition: Acute GVH Disease
Intervention: Biological: Human Umbilical Cord Derived MSC
13 Terminated
Has Results
Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Condition: Graft Versus Host Disease
Interventions: Drug: Visilizumab;   Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Antithymocyte globulin (ATG)
14 Recruiting Phase II Trial of Natalizumab (Tysabri®) Plus Prednisone for Initial Therapy of Acute Graft Versus Host Disease (aGVHD) of the Gastrointestinal Tract
Condition: Graft Versus Host Disease
Interventions: Drug: Natalizumab;   Drug: Methylprednisolone
15 Recruiting Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
Conditions: Graft Versus Host Disease;   GVHD
Interventions: Drug: Panobinostat;   Drug: Sirolimus;   Drug: Tacrolimus
16 Completed
Has Results
Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation
Conditions: Graft Versus Host Disease;   Hematologic Malignancies
Interventions: Drug: Palifermin;   Drug: Placebo;   Other: Conditioning Regimen;   Procedure: Allogeneic stem cell transplant;   Drug: Methotrexate
17 Completed Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease
Condition: Graft-Versus-Host Disease
Intervention: Drug: Pentostatin
18 Terminated Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Interventions: Drug: Rapamycin;   Drug: Tacrolimus
19 Recruiting A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Chronic Graft-versus-host-disease
Interventions: Procedure: Extracorporeal Photopheresis (ECP);   Drug: Interleukin-2
20 Active, not recruiting Bortezomib in Patients With Chronic Graft Versus Host Disease
Condition: Graft Versus Host Disease
Intervention: Drug: Bortezomib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.